初始中轴受累部位影响中轴型脊柱关节炎10年表型演变:DESIR队列数据
基于法国DESIR前瞻性队列662例axSpA患者10年随访数据,按基线炎性中轴痛部位分为颈胸段、腰骶段和弥漫性三组,采用多变量Cox模型分析其与关节外表现及风湿外表现发生的关联。结果显示弥漫性初始中轴受累与后续发生外周关节炎风险独立相关(HR 1.61;95%CI 1.15-2.25),其余关联无统计学意义。
要点
- 弥漫性初始中轴受累的axSpA患者10年内发生外周关节炎风险较腰骶段受累者升高(HR 1.61)。
- 颈胸段、腰骶段与弥漫性三组间,仅弥漫性受累与外周关节炎发生独立相关。
- 初始中轴痛部位有助于axSpA早期风险分层和患者咨询。
核心结论
- 弥漫性初始中轴受累可识别出10年内发生外周关节炎风险增高的axSpA亚组。
研究设计与样本
- 法国DESIR前瞻性队列10年随访数据,纳入662例疾病初发axSpA患者,按基线炎性中轴痛部位分为颈胸段、腰骶段和弥漫性三组。
- 采用多变量Cox模型分析,校正年龄、性别、csDMARDs和bDMARDs暴露(时依协变量)及基线时相应表现的存在。
主要发现
- 662例中颈胸段94例(14.2%)、腰骶段466例(70.3%)、弥漫性102例(15.5%)。
- 弥漫性受累组较其他组年龄更大、教育水平更低、既往指趾炎患病率更低、mSASSS更高。
- 10年随访中,弥漫性受累较腰骶段受累与新发关节炎风险独立相关(HR 1.61;95%CI 1.15-2.25)。
- 未观察到其他显著关联。
关键数值与推荐
- 弥漫性初始中轴受累者10年内新发关节炎风险较腰骶段受累者升高(HR 1.61;95%CI 1.15-2.25)。
临床怎么用
- 对弥漫性初始中轴受累的axSpA患者应加强外周关节炎的监测与早期风险分层。
- 初始中轴痛部位可用于患者咨询及临床试验结局解读。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether the initial location of inflammatory axial pain in axial spondyloarthritis (axSpA) is associated with the development of peripheral or extra-rheumatological manifestations over a 10-year period. METHODS: Data were drawn from the 10-year prospective DESIR (Devenir des Spondylarthropathies Indifférenciées Récentes; French Cohort of Undifferentiated Spondyloarthritis) cohort of axSpA at disease onset. Patients with available data on the initial location of inflammatory axial pain were included. The main outcomes were the occurrence of extra-axial manifestations (arthritis, dactylitis, enthesitis) and extra-rheumatological manifestations (psoriasis, uveitis, inflammatory bowel disease). Patients were categorised according to the initial location of inflammatory axial pain as cervicothoracic, lumbosacral or diffuse (involving both regions). Associations between inflammatory axial pain location and extra-axial or extra-rheumatological manifestations were assessed using multivariate Cox models, adjusted for age, sex, exposure to conventional synthetic and biological disease-modifying antirheumatic drugs (as time-dependent covariates) and the presence of these manifestations at baseline. FRENCH COHORT OF UNDIFFERENTIATED SPONDYLOARTHRITIS : cohort of axSpA at disease onset. Patients with available data on the initial location of inflammatory axial pain were included. The main outcomes were the occurrence of extra-axial manifestations (arthritis, dactylitis, enthesitis) and extra-rheumatological manifestations (psoriasis, uveitis, inflammatory bowel disease). Patients were categorised according to the initial location of inflammatory axial pain as cervicothoracic, lumbosacral or diffuse (involving both regions). Associations between inflammatory axial pain location and extra-axial or extra-rheumatological manifestations were assessed using multivariate Cox models, adjusted for age, sex, exposure to conventional synthetic and biological disease-modifying antirheumatic drugs (as time-dependent covariates) and the presence of these manifestations at baseline. RESULTS: Among 662 included patients, 94 (14.2%) had cervicothoracic, 466 (70.3%) had lumbosacral and 102 (15.5%) had diffuse involvement at baseline. Patients with diffuse involvement were older, had a lower education level, a lower prevalence of prior dactylitis and higher modified Stoke Ankylosing Spondylitis Spinal Score compared with other groups. Over 10 years, diffuse involvement was independently associated with an increased risk of developing arthritis (HR 1.61; 95% CI 1.15 to 2.25) compared with lumbosacral involvement. No other significant associations were observed. CONCLUSION: Diffuse initial axial involvement identifies a subgroup of patients with axSpA at increased risk of developing peripheral arthritis. This finding has practical implications for clinicians in early risk stratification, patient counselling and interpretation of therapeutic trial outcomes.
引用
- Couture AA, Peiffer B, Le Corvoisier P, et al. Influence of initial axial involvement on the phenotypic evolution of axial spondyloarthritis: 10-year data from the DESIR cohort. RMD Open. 2026. PMID: 42557009. doi:10.1136/rmdopen-2026-006837
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。